177 related articles for article (PubMed ID: 37647390)
1. The anti-CD40L monoclonal antibody AT-1501 promotes islet and kidney allograft survival and function in nonhuman primates.
Anwar IJ; Berman DM; DeLaura I; Gao Q; Willman MA; Miller A; Gill A; Gill C; Perrin S; Ricordi C; Ruiz P; Song M; Ladowski JM; Kirk AD; Kenyon NS
Sci Transl Med; 2023 Aug; 15(711):eadf6376. PubMed ID: 37647390
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression With CD40 Costimulatory Blockade Plus Rapamycin for Simultaneous Islet-Kidney Transplantation in Nonhuman Primates.
Oura T; Hotta K; Lei J; Markmann J; Rosales I; Dehnadi A; Kawai K; Ndishabandi D; Smith RN; Cosimi AB; Kawai T
Am J Transplant; 2017 Mar; 17(3):646-656. PubMed ID: 27501203
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD40 ligand antibody permits regeneration through peripheral nerve allografts in a nonhuman primate model.
Brenner MJ; Jensen JN; Lowe JB; Myckatyn TM; Fox IK; Hunter DA; Mohanakumar T; Mackinnon SE
Plast Reconstr Surg; 2004 Dec; 114(7):1802-14; discussion 1815-7. PubMed ID: 15577351
[TBL] [Abstract][Full Text] [Related]
4. ASKP1240, a fully human anti-CD40 monoclonal antibody, prolongs pancreatic islet allograft survival in nonhuman primates.
Watanabe M; Yamashita K; Suzuki T; Kamachi H; Kuraya D; Koshizuka Y; Ogura M; Yoshida T; Aoyagi T; Fukumori D; Shimamura T; Okimura K; Maeta K; Miura T; Sakai F; Todo S
Am J Transplant; 2013 Aug; 13(8):1976-88. PubMed ID: 23841873
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD40 therapy extends renal allograft survival in rhesus macaques.
Pearson TC; Trambley J; Odom K; Anderson DC; Cowan S; Bray R; Lin A; Hollenbaugh D; Aruffo A; Siadak AW; Strobert E; Hennigar R; Larsen CP
Transplantation; 2002 Oct; 74(7):933-40. PubMed ID: 12394833
[TBL] [Abstract][Full Text] [Related]
6. A novel, blocking, Fc-silent anti-CD40 monoclonal antibody prolongs nonhuman primate renal allograft survival in the absence of B cell depletion.
Cordoba F; Wieczorek G; Audet M; Roth L; Schneider MA; Kunkler A; Stuber N; Erard M; Ceci M; Baumgartner R; Apolloni R; Cattini A; Robert G; Ristig D; Munz J; Haeberli L; Grau R; Sickert D; Heusser C; Espie P; Bruns C; Patel D; Rush JS
Am J Transplant; 2015 Nov; 15(11):2825-36. PubMed ID: 26139432
[TBL] [Abstract][Full Text] [Related]
7. Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation.
Montgomery SP; Xu H; Tadaki DK; Celniker A; Burkly LC; Berning JD; Cruzata F; Elster EA; Gray G; Kampen RL; Swanson SJ; Harlan DM; Kirk AD
Transplantation; 2002 Nov; 74(10):1365-9. PubMed ID: 12451232
[TBL] [Abstract][Full Text] [Related]
8. CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study.
Shock A; Burkly L; Wakefield I; Peters C; Garber E; Ferrant J; Taylor FR; Su L; Hsu YM; Hutto D; Amirkhosravi A; Meyer T; Francis J; Malcolm S; Robinson M; Brown D; Shaw S; Foulkes R; Lawson A; Harari O; Bourne T; Maloney A; Weir N
Arthritis Res Ther; 2015 Sep; 17(1):234. PubMed ID: 26335795
[TBL] [Abstract][Full Text] [Related]
9. Fc-Silent Anti-CD154 Domain Antibody Effectively Prevents Nonhuman Primate Renal Allograft Rejection.
Kim SC; Wakwe W; Higginbotham LB; Mathews DV; Breeden CP; Stephenson AC; Jenkins J; Strobert E; Price K; Price L; Kuhn R; Wang H; Yamniuk A; Suchard S; Farris AB; Pearson TC; Larsen CP; Ford ML; Suri A; Nadler S; Adams AB
Am J Transplant; 2017 May; 17(5):1182-1192. PubMed ID: 28097811
[TBL] [Abstract][Full Text] [Related]
10. Prolonged survival of allogeneic islets in cynomolgus monkeys after short-term anti-CD154-based therapy: nonimmunologic graft failure?
Koulmanda M; Smith RN; Qipo A; Weir G; Auchincloss H; Strom TB
Am J Transplant; 2006 Apr; 6(4):687-96. PubMed ID: 16539625
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of ABI793, a novel human anti-human CD154 monoclonal antibody, in cynomolgus monkey renal allotransplantation.
Schuler W; Bigaud M; Brinkmann V; Di Padova F; Geisse S; Gram H; Hungerford V; Kleuser B; Kristofic C; Menninger K; Tees R; Wieczorek G; Wilt C; Wioland C; Zurini M
Transplantation; 2004 Mar; 77(5):717-26. PubMed ID: 15021835
[TBL] [Abstract][Full Text] [Related]
12. Short-term therapy with anti-ICAM-1 monoclonal antibody induced long-term liver allograft survival in nonhuman primates.
Hong SK; Han D; Lee SK; Kim J; Hwang ES; Kim H; Lee JI; Hong K; Han ES; Cho JH; Lee JM; Choi Y; Lee KW; Yi NJ; Yang J; Suh KS
Am J Transplant; 2021 Sep; 21(9):2978-2991. PubMed ID: 33423374
[TBL] [Abstract][Full Text] [Related]
13. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
14. Gene transfer of human CD40Ig does not prevent rejection in a non-human primate kidney allotransplantation model.
Angin M; Poirier N; Dilek N; Le Guiner C; Toromanoff A; Blancher A; Cherel Y; Deschamps JY; Tillou X; Renaudin K; Minault D; Hervouet J; Blancho G; Vanhove B; Anegon I; Le Mauff B
Transpl Immunol; 2012 Dec; 27(4):139-45. PubMed ID: 23098770
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
Kenyon NS; Fernandez LA; Lehmann R; Masetti M; Ranuncoli A; Chatzipetrou M; Iaria G; Han D; Wagner JL; Ruiz P; Berho M; Inverardi L; Alejandro R; Mintz DH; Kirk AD; Harlan DM; Burkly LC; Ricordi C
Diabetes; 1999 Jul; 48(7):1473-81. PubMed ID: 10389857
[TBL] [Abstract][Full Text] [Related]
16. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates.
Kirk AD; Harlan DM; Armstrong NN; Davis TA; Dong Y; Gray GS; Hong X; Thomas D; Fechner JH; Knechtle SJ
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8789-94. PubMed ID: 9238056
[TBL] [Abstract][Full Text] [Related]
17. Promises and obstacles for the blockade of CD40-CD40L interactions in allotransplantation.
Li XL; Ménoret S; Le Mauff B; Angin M; Anegon I
Transplantation; 2008 Jul; 86(1):10-5. PubMed ID: 18622269
[TBL] [Abstract][Full Text] [Related]
18. TNX-1500, a crystallizable fragment-modified anti-CD154 antibody, prolongs nonhuman primate renal allograft survival.
Lassiter G; Otsuka R; Hirose T; Rosales I; Karadagi A; Tomosugi T; Dehnadi A; Lee H; Colvin RB; Baardsnes J; Moraitis A; Smith EE; Ali Z; Berhe P; Mulder A; Meibohm B; Daugherty B; Fogarty S; Pierson RN; Lederman S; Kawai T
Am J Transplant; 2023 Aug; 23(8):1171-1181. PubMed ID: 37019335
[TBL] [Abstract][Full Text] [Related]
19. Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow Transplantation.
Oura T; Ko DS; Boskovic S; O'Neil JJ; Chipashvili V; Koulmanda M; Hotta K; Kawai K; Nadazdin O; Smith RN; Cosimi AB; Kawai T
Cell Transplant; 2016; 25(7):1331-41. PubMed ID: 26337731
[TBL] [Abstract][Full Text] [Related]
20. TNX-1500, a crystallizable fragment-modified anti-CD154 antibody, prolongs nonhuman primate cardiac allograft survival.
Miura S; Habibabady ZA; Pollok F; Ma M; Rosales IA; Kinoshita K; Pratts S; McGrath G; Chaban R; Fogarty S; Meibohm B; Daugherty B; Lederman S; Pierson RN
Am J Transplant; 2023 Aug; 23(8):1182-1193. PubMed ID: 37030662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
